[ORGANIZATION]
Saxenda
Featured in 2 tracked stories · first seen
Situations
GLP-1 drugs: clinical trends, safety, and market shifts
214 clusters · 795 sources · last updated
Latest: GLP-1 medications drive shift in obesity management and healthcare strategy
Since mid-2026, the expansion of GLP-1 agents for obesity has been accompanied by intensified safety monitoring and evolving clinical data. While research suggests secondary benefits—including a 21% lower risk of fragili
Adverse reactions to weight loss medications
2 clusters · 4 sources · last updated
Latest: Weight-loss injections linked to reports of severe side effects and deaths
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has reported significant adverse reactions associated with weight-loss medications including Mounjaro (tirzepatide), Wegovy (semaglutide), and Saxenda (li